Schistosomiasis causes significant levels of morbidity and mortality in many geographical
regions of the world. The disease is caused by infections with parasitic blood flukes known …

The Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) was
funded in 2008 to conduct research that would support country schistosomiasis control …

Schistosomiasis treatment relies on the use of a single drug, praziquantel, which is
insufficient to control transmission in highly endemic areas. Novel medicines and vaccines …

Malaria and schistosomiasis are two major parasitic diseases that remain leading causes of
morbidity and mortality worldwide. Co-infections of these two parasites are common in the …

Helminth diseases are the ancient scourges of humans and their damages are 'silent and
insidious'. Of the helminth infections, schistosomiasis and hookworm infection have a great …

Schistosomiasis is a parasitic disease caused by trematode blood flukes of the genus
Schistosoma, affecting over 250 million people mainly in the tropics. Clinically, the disease …

Three vaccines against human schistosomiasis are in different phases of clinical
development, and a fourth is expected to enter the clinic soon. Successful introduction of an …

Despite mass drug administration programmes with praziquantel, the prevalence of
schistosomiasis remains high. A vaccine is urgently needed to control transmission of this …

Schistosomiasis is of public health importance to an estimated one billion people in 79
countries. A vaccine is urgently needed. Here, we report the results of four independent …

Though the immunity to malaria has been associated with cellular immune responses, the
exact function of the phenotypic cell population is still unclear. This study investigated the …